Swine flu affecting the young and expert suspects virus mutation

Health minister’s statement in parliament makes it clear that there is no mutation and there is no shortage of drugs

GN Bureau | February 25, 2015


#swine flu   #drug   #health   #deaths   #mutation   #virus   #nadda   #ahmed   #h1n1  


Even as India says that there is no mutation of swine flu virus, an expert has sought deeper investigation on mutation factor as more young Indians are falling prey to the disease.

Rafi Ahmed, Director of Emory Vaccine Centre in Atlanta, US, has called on the Indian researchers to immediately ascertain whether the present swine flu virus has mutated or not.

Dr Ahmed, who is also a member of the advisory committee of the Department of Biotechnology, said on Tuesday that the H1N1 virus was killing a significant number of young adults in India.

 “We saw this happening during Spanish Flu in 1918 when 50-100 million people died, and young people were a majority. There is an urgent need to sequence the Indian swine flu virus to find out whether there is a new strain or the old one. The mortality rate among the young people… is worrisome.”

Ahmed, a world-renowned scientist in viral pathogenesis, has also called for screening the samples for H3N2 and influenza type B besides H1N1 virus. He has also recommended that instead of the current monovalent vaccine which targets only H1N1, India should go for a trivalent vaccine to provide protection from H2N3 and type B as well.

However, union health minister J P Nadda made a statement in parliament on Tuesday and made it clear that the cases of Influenza A currently being reported are of H1N1 which is the same virus which took a huge toll during 2009 and there is “no mutation” in the virus.

“It has been confirmed, both by National Institute of Virology (under ICMR) and National Centre for Diseases Control, (Delhi) that the cases of Influenza A currently being reported are of H1N1.

“It is the same virus of 2009 and there is no mutation in the virus. Consequently, the drug Oseltamivir used during the time of pandemic 2009-2010 remains effective for treatment now also,” he said in the statement amid fears that the virus might have mutated.

He said in the current year, from January 1 till February 22, 2015, the number of cases reported by the states is 14673 while the number of deaths for the same period are 841.

Nadda said that his ministry has recommended vaccine only for the healthcare workers whose guidelines have been sent to the state governments.

“This decision has been taken after due consultations with experts. Vaccination of general public is not advocated as a public health strategy at this juncture,” he said.

He said that Oseltamivir cannot be sold over the counter and is made available only against prescription by a qualified doctor and sold through a chemist with license under Schedule X of the Drugs and Cosmetics Act while it also available through the public health system.

“We cannot afford a situation where due to irrational use of the drug, resistance is developed, rendering the drug incapable of fighting the virus.

Comments

 

Other News

PM Surya Ghar: Muft Bijli Yojana completes first year

On February 13, 2025, the PM Surya Ghar: Muft Bijli Yojana (PMSGMBY) will mark its first anniversary, celebrating a year of empowering households with affordable solar energy and accelerating India’s transition to a sustainable future. Launched by prime minister Narendra Modi on Febru

How to leverage AI to solve urgent global issues

The world seems to be hurling towards World War III in all the possible scenarios: hot war, cold war, and proxy war. The battleground seems to have expanded beyond physical to digital or virtual/mixed reality with technology like drones. Moreover, the line between civilian and military targets seems to hav

Budget: Progress towards SDGs and areas for improvement

The Union Budget 2025-26 outlines India`s vision for economic and social growth while also reflecting the country`s commitment to sustainable development. As India moves closer to the 2030 deadline for the United Nations’ Sustainable Development Goals (SDGs), this budget presents a balanced approach

Repo rate cut by 25 basis points to 6.25%

The Reserve Bank of India has, for the first time in five years, reduced the policy repo rate under the liquidity adjustment facility (LAF) by 25 basis points to 6.25% with immediate effect. Consequently, the standing deposit facility (SDF) rate will stand adjusted to 6.00% and the marginal

Amitav Ghosh’s new work: Connections between the word and the world

Wild Fictions: Essays By Amitav Ghosh HarperCollins, 496 pages, Rs 799.00 Amitav Ghosh, one of a handful of Ind

How markets can help (and also hinder) fight against pollution

In the annals of environmental policy, few ideas have been as transformative as the Emissions Trading System (ETS). Born from the minds of economists in the late 1960s, this market-based approach to pollution control has evolved from a theoretical concept to a global tool in the fight against climate chang

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now



Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter